文献速递主动脉疾病

丹麦全国性感染性原生腹主动脉瘤手术治疗研究

Danish Nationwide Study on Surgical Treatment of Infective Native Abdominal Aortic Aneurysms.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2023-11-07

该回顾性全国队列研究纳入丹麦2000至2020年因腹主动脉感染性原生动脉瘤接受手术的全部75例患者,开放修复54例(72%)、腔内修复21例(28%)。全队列30天生存率97%,1、3、5、10年生存率分别为92%、80%、63%、48%;腔内修复长期生存与开放修复相当(HR 0.35,95%CI 0.10-1.22),但5年内短期生存更优。最常见死因为脓毒症,术后感染相关并发症发生率低。

要点

  • 开放修复全程为主要术式,但腔内修复使用随时间增加。
  • 全队列30天生存率97%,5年生存率63%,10年生存率48%。
  • 腔内修复长期生存与开放修复相当(HR 0.35,95%CI 0.10-1.22),5年内短期生存更优。

核心结论

  • 在本全国性腹主动脉感染性原生动脉瘤手术患者研究中,研究期间手术患者数量增加,腔内修复长期生存与开放修复相当,术后感染相关并发症发生率低,结果需谨慎解读且需要前瞻性登记研究。

研究设计与样本

  • 回顾性全国队列研究,纳入丹麦2000至2020年因腹主动脉感染性原生动脉瘤接受手术的全部患者,通过丹麦血管登记数据库Karbase识别,临床资料来自电子病历。
  • 共纳入75例患者,其中男性60例(80%),中位年龄69岁(IQR 64,75)。
  • 开放手术修复54例(72%),腔内主动脉修复21例(28%);中位随访52个月(IQR 32,103)。

主要发现

  • 全队列30天生存率为97%(94-100%)。
  • Kaplan-Meier生存估计1年92%(95%CI 85-98%)、3年80%(95%CI 71-91%)、5年63%(95%CI 52-78%)、10年48%(95%CI 35-66%)。
  • 腔内修复患者长期生存与开放修复相当,风险比HR 0.35(95%CI 0.10-1.22),但5年内短期生存更优。
  • 最常见死因为脓毒症;开放修复患者术后感染相关并发症5例(9%),腔内修复患者1例(5%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出结果应谨慎解读,需要前瞻性登记研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to describe surgical trends, survival, and infection related complications (IRC) in a Danish cohort of patients with infective native aortic aneurysms (INAAs). METHODS: A retrospective nationwide cohort study including all patients in Denmark who were surgically treated for abdominal INAA between 2000 and 2020 was conducted. Patients were identified through the Danish vascular registry, Karbase, which is a database registering all patients treated with vascular surgery in Denmark. Subsequent data on clinical presentation, treatment, all cause mortality, and complications were obtained from the electronic patient charts. RESULTS: Seventy-five patients were included in the study, of whom 60 (80%) were male, with a median age of 69 (IQR 64, 75) years. Open surgical repair (OSR) was performed in 54 (72%) patients and endovascular aortic repair (EVAR) in 21 (28%). Median follow up was 52 (IQR 32, 103) months. Open repair was consistently the most frequent treatment modality throughout the study period, but EVAR became more frequent over time. The 30 day survival of the total cohort was 97% (94 - 100%). Kaplan-Meier survival estimates for the cohort were 92% (95% CI 85 - 98%), 80% (95% CI 71 - 91%), 63% (95% CI 52 - 78%), and 48% (95% CI 35 - 66%) at one, three, five and 10 years, respectively. Patients treated by EVAR had comparable long term survival to patients treated by OSR, with a hazard ratio of 0.35 (95% CI 0.10 - 1.22), but was associated with better short term survival up to five years. The most common cause of death was sepsis. Five (9%) OSR patients had IRC compared with one (5%) EVAR patient. CONCLUSION: In this nationwide study of patients treated for abdominal INAA, an increasing number of patients were surgically treated during the study period. Patients treated by EVAR demonstrated long term survival comparable to OSR. The incidence of post-operative IRC was low. These results should be interpreted with caution and prospective registries are needed.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Skov RAC, Lawaetz M, Eldrup N, et al. Danish Nationwide Study on Surgical Treatment of Infective Native Abdominal Aortic Aneurysms. Eur J Vasc Endovasc Surg. 2023. PMID: 37944790. doi:10.1016/j.ejvs.2023.11.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。